0001127602-20-022237.txt : 20200729
0001127602-20-022237.hdr.sgml : 20200729
20200729174118
ACCESSION NUMBER: 0001127602-20-022237
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200727
FILED AS OF DATE: 20200729
DATE AS OF CHANGE: 20200729
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zaks Tal Zvi
CENTRAL INDEX KEY: 0001690927
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38753
FILM NUMBER: 201058199
MAIL ADDRESS:
STREET 1: 122 BELLEVUE STREET
CITY: NEWTON
STATE: MA
ZIP: 02458
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Moderna, Inc.
CENTRAL INDEX KEY: 0001682852
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 813467528
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6177146500
MAIL ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Moderna Therapeutics, Inc.
DATE OF NAME CHANGE: 20160822
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-07-27
0001682852
Moderna, Inc.
MRNA
0001690927
Zaks Tal Zvi
C/O MODERNA, INC.
200 TECHNOLOGY SQUARE
CAMBRIDGE
MA
02139
1
Chief Medical Officer
Common Stock
2020-07-27
4
M
0
10000
20.93
A
10000
D
Common Stock
2020-07-27
4
M
0
10000
19.15
A
20000
D
Common Stock
2020-07-27
4
S
0
2384
76.79
D
17616
D
Common Stock
2020-07-27
4
S
0
3940
77.68
D
13676
D
Common Stock
2020-07-27
4
S
0
5548
78.73
D
8128
D
Common Stock
2020-07-27
4
S
0
7228
79.72
D
900
D
Common Stock
2020-07-27
4
S
0
900
80.43
D
0
D
Stock Option (Right to Buy)
20.93
2020-07-27
4
M
0
10000
0
D
2020-03-08
2029-03-08
Common Stock
10000
299195
D
Stock Option (Right to Buy)
19.15
2020-07-27
4
M
0
10000
0
D
2026-08-10
Common Stock
10000
204790
D
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $76.19 to $77.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.20 to $78.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $78.21 to $79.20. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $79.22 to $80.20. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $80.27 to $80.61. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
This option is fully vested and exercisable.
This option is fully vested and exercisable.
/s/ Lori Henderson, as Attorney-in-Fact
2020-07-29